In this issue:
  -  Urgency vs. triage prioritisation appropriateness of NZ dermatology referrals
  -  Adjuvant cemiplimab for high-risk cutaneous SCC
  -  Narrative vs. structured pathology reporting for cutaneous SCC
  -  Anti-PD-1 therapy in unresectable desmoplastic melanoma
  -  Characterisation of different clinical presentations of MCC
  -  Inherited mitochondrial genetics for predicting ICI efficacy in melanoma
  -  SPOTS: skin cancer prevention educational programme for adolescents
  -  Pembrolizumab-related toxicities in advanced melanoma
  -  Melanoma in pregnancy
    
    
    
      
      
        
        
        
          Please login below to download this issue (PDF)